LaSalle St. Investment Advisors LLC Has $1.12 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

LaSalle St. Investment Advisors LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 33.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,209 shares of the healthcare conglomerate's stock after purchasing an additional 548 shares during the period. LaSalle St. Investment Advisors LLC's holdings in UnitedHealth Group were worth $1,117,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of UNH. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at about $25,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $30,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $32,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Mizuho lifted their price objective on UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Finally, Truist Financial upped their price target on UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a report on Friday. Twenty-one investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Buy" and an average price target of $632.85.

Remove Ads

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Trading Down 0.6 %

NYSE:UNH traded down $3.63 during trading hours on Tuesday, hitting $583.43. The stock had a trading volume of 3,865,335 shares, compared to its average volume of 4,340,638. The business's 50 day moving average is $513.80 and its 200-day moving average is $541.83. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market cap of $533.67 billion, a price-to-earnings ratio of 37.64, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a one year low of $438.50 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the business posted $5.83 EPS. The company's revenue for the quarter was up 6.8% on a year-over-year basis. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.44%. UnitedHealth Group's dividend payout ratio is presently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.